Twenty-four patients with acute on chronic liver failure were randomised to receive standard therapy , standard therapy + granulocyte-colony stimulating factor ( 5 microg/kg/day for 6 days ) and standard therapy + granulocyte-colony stimulating factor ( 15 microg/kg/day s.c. for 6 days ) .
